Conception Kit(R) At-Home System Goes to Market, Helps

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Conception Kit(R) At-Home System Goes to Market, Helps Couples Get Pregnant During Regular Sex Launched By Conceivex, Inc.

BLOOMFIELD HILLS, Mich., Nov. 3, 2015 (GLOBE NEWSWIRE) -- via PRWEB - The Conception Kit® at-home system from Conceivex, Inc. is a comprehensive fertility treatment enabling couples to determine the optimal time to get pregnant and includes an innovative cervical cap protecting and concentrating semen around the cervical opening to increase the chances for sperm to penetrate the cervix to fertilize the egg.

The Conception Kit® at-home system contains a comprehensive collection of materials including 24 ovulation predictors, three pregnancy tests, and the innovative Conception Cap®. Patients who purchased the same amount of over-the-counter (OTC) ovulation predictors and pregnancy tests are provided in one Conception Kit® would spend in excess of $75. In comparison, the Conception Kit® at-home system is FDA cleared and now available for many patients as a prescription benefit under most insurance policies for a co-pay of $20-$50.

According to the National Women's Health Resource Center , even couples between the ages of 29-33 with normal functioning reproductive systems have just a 20-25% chance of getting pregnant during any given month. For couples with infertility challenges, this percentage drops even more. Thankfully, there is an innovative early treatment option available to couples to help them optimize the chances of getting pregnant in the comfort of their own home.

"Ovulation predictors can only pin point the best time for conception to occur during the luteinizing hormone surge (LH surge) which signals the follicle to release the egg," shares Michael La Vean, President of Conceivex, Inc. "The Conception Kit® at-home system is designed to help couples maximize their chances for conception during this time by addressing fertility issues such as low sperm count, low sperm motility, and unbalanced PH levels."

The Conception Kit® at-home system, is a natural, drug–free treatment using cervical cap insemination and timed ovulation which is done in the privacy of the patient's home. It is the only FDA cleared treatment for low sperm count and sperm motility, a tilted cervix, or a hostile vaginal environment that is covered by insurance. The Conception Kit® is eligible for reimbursement from several pharmacy benefit managers, making this a simple co-pay at the pharmacy for patient's that have this as part of the insurance plan. To obtain a Conception Kit® a prescription from a medical provider is needed.

Couples who are trying to get pregnant can now, go beyond basic ovulation timing, by using at-home cervical cap insemination and timed ovulation with the Conception Kit® at-home system. Couples who are interested in learning more about the Conception Kit® at-home system should speak with their doctor during the first twelve months of trying to conceive. The Conception Kit® at-home system is an affordable prescription fertility treatment, which addresses shared infertility factors such as PH imbalance, low sperm motility, and low sperm count. Thanks to the Conception Kit® at-home system, couples can

According to the American Society for Reproductive Medicine (ASRM), infertility affects men and women equally. In approximately 40 percent of infertile couples the male partner is either the sole cause or a contributing cause of infertility. The Conception Kit® at-home system is a three month comprehensive program to address some of the most common fertility issues to help couples get pregnant. The treatment is FDA-cleared and includes components to track female ovulation and the innovative Conception Cap®, which is a cervical cap designed to concentrate all available sperm at the cervical opening during the best time for conception to occur.

When it comes to conceiving a child, there are many complex biological factors that must line up to be successful. The Conception Kit® at-home system was developed to reduce negative factors and create an ideal environment in which sperm are better able to penetrate the cervix and move towards the egg.

The Conception Cap® protects sperm from dangerous PH levels inside the vaginal environment and concentrates sperm directly on the cervical opening. Sperm can live inside the Conception Cap® for six hours or more. This is very important when you consider that 90% of all sperm die within the first ten minutes inside the vagina due to the vagina's environment. M.Sara Rosentahl, Massod A Khatamee, M.D. F.A.C.O.G., The Fertility Sourcebook third edition, Page 98. When facing low sperm count or low sperm motility, this protective environment enables every sperm cell to move closer to the egg as they swim through the cervical mucus and into the uterus. Once inside the uterus, the sperm cells move into the fallopian tube in search of the egg.

The Conception Kit® at-home system is also an ideal treatment to use in combination with fertility medications to optimizes the amount of sperm that reaches the cervical opening while the woman is maximizing her egg production during each prescribed fertility medication cycle. The Conception Kit® at- home system is a pharmacy covered benefit with many insurance policies making this a simple copay at the pharmacy. Couples who are interested in taking this early step together should contact their medical provider to learn more about the Conception Kit® at-home system.

"Whether a patient is trying to get pregnant with a first baby or adding to a growing family, conceiving a child is not always easy," shares Mr. La Vean. "The Conception Kit® at-home system is a comprehensive, FDA-cleared medical device designed to go beyond ovulation timing and overcome common fertility problems such as low sperm count, low sperm motility, and PH imbalance."

With the Conception Kit® at-home system, couples can take charge of their family planning in the comfort and privacy of their own home. The Conception Kit® is now available by prescription at Target, Walmart, Rite Aid and CVS pharmacies nationwide.

About Conceivex Inc.

The mission of Conceivex Inc. is to give women and couples health care products that assist them in reaching their reproductive goals. Currently, one in six women is looking for help becoming pregnant. This is why Conceivex manufactures and distributes the Conception Kit® at-home system, a safe, effective, and reasonably priced method to help women and couples overcome infertility in the privacy of their own home. The Conception Kit® at-home system is FDA cleared and easy to use.

Conceivex, Inc. 4111 Andover Road, West Third Floor Bloomfield Hills, MI 48302 Tel: (855) 910-9222

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/get-pregnant/co...058682.htm

Conceivex, Inc. Melih Oztalay +1 (248) 568-2241

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 268

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 84

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of the Sodium Bisulfite Market by 2034

Updated Category News Views 133

Understanding the Growth of the Sodium Bisulfite Market The sodium bisulfite market is experiencing significant momentum as it progresses towards a bright future, with expectations of reaching USD 1,180.7 million by 2034, up from USD 750.3 million in 2024. This growth is driven by an increasing awareness of environmental issues and its versatile applications in various...

Continue Reading
Photocure ASA Reports Impressive Q2 Growth and Outlook

Updated Category News Views 153

Photocure ASA Achieves Record Revenue in Q2 Photocure ASA has shared strong results for the second quarter of the year, showcasing remarkable growth in its Hexvix/Cysview product line. This quarter marked an unprecedented achievement with revenues reaching NOK 135.6 million, reflecting a significant increase compared to NOK 122.4 million from the same period last year....

Continue Reading
Ben & Jerry's Unveils New Flavor Inspired by Noah Kahan

Updated Category News Views 273

Ben & Jerry's Launches Exclusive Flavor with Noah Kahan Ben & Jerry's, the iconic ice cream brand that loves to explore creative flavors, has just introduced an exciting new flavor called Northern Latte-tude. This one-of-a-kind creation is the result of a collaboration with musician Noah Kahan, with the goal of not only delighting fans but also supporting an important...

Continue Reading
Cisco Analyst Coverage Initiation Highlights: Stocks to Watch

Updated Category News Views 141

Latest Analyst Ratings on Notable Stocks In a dynamic market environment, top analysts analyze and provide insights on various companies. Recently, several key analysts have shared significant ratings and price targets for notable stocks, including Cisco Systems, Inc. (NASDAQ: CSCO) and Shopify Inc. (NASDAQ: SHOP). Let's delve into what they have to say. Shopify Inc....

Continue Reading
Nike's Leadership Shakeup: A Bright Future Ahead for the Brand

Updated Category News Views 205

Nike's Steady Outlook Amid Leadership Changes BMO Capital Markets has recently reaffirmed its Outperform rating for Nike Inc. (NYSE:NKE), setting a price target at $92.00 per share. This positive outlook follows the recent appointment of Elliott Hill as President and CEO, a change many investors have eagerly awaited. Hill's return is seen as a hopeful sign for the...

Continue Reading